Shen et al. reported that toll-like receptor 4 (TLR4) promotes high glucose and high fat-induced osteoclast differentiation by inhibiting FTO-mediated m6A modification, suggesting that m6A modification participated in developing diabetic bone loss121. The gene discussed is TLR4; the disease is diabetes mellitus.